Journal
NATURE REVIEWS CANCER
Volume 2, Issue 2, Pages 101-+Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc721
Keywords
-
Categories
Ask authors/readers for more resources
Deaths from breast cancer have fallen markedly over the past decade due, in part, to the use of endocrine agents that reduce the levels of circulating oestrogens or compete with oestrogen for binding to its receptor. However, many breast tumours either fail to respond or become resistant to endocrine therapies. By understanding the mechanisms that underlie this resistance, we might be able to develop strategies for overcoming or bypassing it.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available